Pfizer Testing Vaccine In 4 States

Pfizer is launching a pilot program in four states to test the distribution of its COVID-19 vaccine, chosen for their diverse characteristics. A major challenge is maintaining the vaccine at minus 94 degrees Fahrenheit during storage and shipping. Pfizer's vaccine has shown over 90% effectiveness, while Moderna's vaccine has reported over 94% effectiveness.

Why did Pfizer choose the four states for its pilot program?

• They are geographically close to each other.

• They have the largest populations.

• They vary in size, diversity, and infrastructure.

• They have the highest COVID-19 cases.

What is a major logistical challenge Pfizer is trying to solve for its vaccine?

• Cold storage for shipping and storing the vaccine.

• Ensuring the vaccine is affordable.

• Finding volunteers for trials.

• Developing a new vaccine formula.

At what temperature must Pfizer's vaccine be stored?

• Minus 50 degrees Fahrenheit

• Minus 94 degrees Fahrenheit

• Zero degrees Fahrenheit

• Minus 32 degrees Fahrenheit

What effectiveness did Pfizer announce for its potential vaccine?

• 80% effective

• 95% effective

• 85% effective

• 90% effective

How effective did Moderna report its experimental vaccine to be?

• 88% effective

• 92% effective

• 94% effective

• 96% effective